• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dendritic cell biology and cancer therapy.树突状细胞生物学与癌症治疗。
Cancer Immunol Immunother. 2004 Mar;53(3):240-8. doi: 10.1007/s00262-003-0468-6. Epub 2003 Dec 18.
2
Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.从树突状细胞中去除唾液酸可改善抗原交叉呈递并增强抗肿瘤免疫反应。
Oncotarget. 2016 Jul 5;7(27):41053-41066. doi: 10.18632/oncotarget.9419.
3
Cancer immunotherapy via dendritic cells.通过树突状细胞进行癌症免疫疗法。
Nat Rev Cancer. 2012 Mar 22;12(4):265-77. doi: 10.1038/nrc3258.
4
Dendritic cell biology and its role in tumor immunotherapy.树突状细胞生物学及其在肿瘤免疫治疗中的作用。
J Hematol Oncol. 2020 Aug 3;13(1):107. doi: 10.1186/s13045-020-00939-6.
5
Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.诱导针对人喉癌衍生抗原的细胞毒性T淋巴细胞:对用热处理肿瘤裂解物脉冲的树突状细胞及基于树突状细胞疫苗接种的其他抗原加载策略的评估
J Exp Clin Cancer Res. 2016 Jan 22;35:18. doi: 10.1186/s13046-016-0295-1.
6
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.树突状细胞免疫疗法:从体外负载到体内靶向
Nat Rev Immunol. 2007 Oct;7(10):790-802. doi: 10.1038/nri2173.
7
Dendritic Cells and Cancer Immunity.树突状细胞与癌症免疫
Trends Immunol. 2016 Dec;37(12):855-865. doi: 10.1016/j.it.2016.09.006. Epub 2016 Oct 25.
8
Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.树突状细胞-肿瘤细胞杂交体增强针对小鼠结肠癌的细胞毒性T淋巴细胞诱导:免疫治疗性树突状细胞疫苗接种抗原加载方法的比较分析
Oncol Rep. 2006 Dec;16(6):1317-24.
9
Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells.探索癌症免疫治疗中的树突状细胞亚群:揭示成熟调节性树突状细胞的作用。
Ups J Med Sci. 2024 Apr 12;129. doi: 10.48101/ujms.v129.10627. eCollection 2024.
10
Therapeutic dendritic cell-based cancer vaccines: the state of the art.基于治疗性树突状细胞的癌症疫苗:现状
Crit Rev Immunol. 2013;33(6):489-547. doi: 10.1615/critrevimmunol.2013008033.

引用本文的文献

1
ZG16 enhances the maturation of dendritic cells via induction of CD40 and contributes to the antitumor immunity in pancreatic cancer.ZG16 通过诱导 CD40 增强树突状细胞的成熟,并有助于胰腺癌的抗肿瘤免疫。
Oncogene. 2024 Oct;43(43):3184-3196. doi: 10.1038/s41388-024-03154-6. Epub 2024 Sep 11.
2
Langerhans Cells in Sentinel Lymph Nodes from Melanoma Patients.黑色素瘤患者前哨淋巴结中的朗格汉斯细胞。
Cancers (Basel). 2024 May 16;16(10):1890. doi: 10.3390/cancers16101890.
3
cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors.cGAS-STING 通路介导树突状细胞对免疫原性肿瘤的感应激活。
Cell Mol Life Sci. 2024 Mar 21;81(1):149. doi: 10.1007/s00018-024-05191-6.
4
Perspective view of allogeneic IgG tumor immunotherapy.同种异体IgG肿瘤免疫疗法的透视图。
Cancer Cell Int. 2024 Mar 9;24(1):100. doi: 10.1186/s12935-024-03290-9.
5
Nanoparticle vaccines can be designed to induce pDC support of mDCs for increased antigen display.纳米颗粒疫苗可设计为诱导 pDC 支持 mDC 以增加抗原呈递。
Biomater Sci. 2023 Jan 17;11(2):596-610. doi: 10.1039/d2bm01132h.
6
Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies.通过Fcγ受体靶向的树突状细胞瘤疫苗接种:临床前和转化研究的经验教训
Vaccines (Basel). 2021 Apr 20;9(4):409. doi: 10.3390/vaccines9040409.
7
Current trends in cancer immunotherapy: a literature-mining analysis.当前癌症免疫疗法的趋势:文献挖掘分析。
Cancer Immunol Immunother. 2020 Dec;69(12):2425-2439. doi: 10.1007/s00262-020-02630-8. Epub 2020 Jun 15.
8
Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity.树突状细胞与免疫原性癌细胞死亡:改善抗肿瘤免疫的组合
Pharmaceutics. 2020 Mar 12;12(3):256. doi: 10.3390/pharmaceutics12030256.
9
Splenic CD11c(low)CD45RB(high) dendritic cells derived from endotoxin-tolerant mice attenuate experimental acute liver failure.来自内毒素耐受小鼠的脾脏 CD11c(low)CD45RB(high)树突状细胞可减轻实验性急性肝衰竭。
Sci Rep. 2016 Sep 14;6:33206. doi: 10.1038/srep33206.
10
Phenotypic and functional comparison of two distinct subsets of programmable cell of monocytic origin (PCMOs)-derived dendritic cells with conventional monocyte-derived dendritic cells.源自单核细胞的可编程细胞(PCMOs)的两个不同亚群衍生的树突状细胞与传统单核细胞衍生的树突状细胞的表型和功能比较。
Cell Mol Immunol. 2016 Mar;13(2):160-9. doi: 10.1038/cmi.2014.135. Epub 2015 Feb 9.

本文引用的文献

1
Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: implications for immunotherapy.癌症患者肿瘤微环境和外周循环中免疫细胞的凋亡:对免疫治疗的影响。
Vaccine. 2002 Dec 19;20 Suppl 4:A46-51. doi: 10.1016/s0264-410x(02)00387-0.
2
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma.HLA-DRB10401(+) 肾细胞癌或黑色素瘤患者中,1型辅助性T细胞(Th1)/2型辅助性T细胞(Th2)CD4(+) T细胞对MAGE-6反应的疾病相关偏差
J Exp Med. 2002 Sep 2;196(5):619-28. doi: 10.1084/jem.20012142.
3
Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses.CD8⁺和CD4⁺T细胞的互补性树突状细胞激活功能:CD8⁺T细胞在1型辅助性T细胞反应发育中的辅助作用。
J Exp Med. 2002 Feb 18;195(4):473-83. doi: 10.1084/jem.20011662.
4
Dendritic cells: immune regulators in health and disease.树突状细胞:健康与疾病中的免疫调节因子
Physiol Rev. 2002 Jan;82(1):97-130. doi: 10.1152/physrev.00023.2001.
5
The plasticity of dendritic cell responses to pathogens and their components.树突状细胞对病原体及其成分反应的可塑性。
Science. 2001 Oct 26;294(5543):870-5. doi: 10.1126/science.294.5543.870.
6
Dendritic cell biology and regulation of dendritic cell trafficking by chemokines.树突状细胞生物学以及趋化因子对树突状细胞迁移的调控
Springer Semin Immunopathol. 2000;22(4):345-69. doi: 10.1007/s002810000053.
7
Antigen-presenting cells. Experimental and clinical studies of dendritic cells.抗原呈递细胞。树突状细胞的实验与临床研究。
Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 2):S146-50. doi: 10.1164/ajrccm.162.supplement_3.15tac1a.
8
Antigen-processing machinery breakdown and tumor growth.抗原加工机制破坏与肿瘤生长
Immunol Today. 2000 Sep;21(9):455-64. doi: 10.1016/s0167-5699(00)01692-3.
9
IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells.白细胞介素-4是人类辅助性T细胞2型诱导白细胞介素-12 p70的介质:树突状细胞使极化的辅助性T细胞2型表型逆转。
J Immunol. 2000 Aug 15;165(4):1877-81. doi: 10.4049/jimmunol.165.4.1877.
10
Dendritic cells: immunological sentinels with a central role in health and disease.树突状细胞:在健康与疾病中起核心作用的免疫哨兵。
Immunol Cell Biol. 2000 Apr;78(2):91-102. doi: 10.1046/j.1440-1711.2000.00888.x.

树突状细胞生物学与癌症治疗。

Dendritic cell biology and cancer therapy.

作者信息

Whiteside Theresa L, Odoux Christine

机构信息

Research Pavilion at the Hillman Cancer Center, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Suite 1.27, PA 15213-1863, Pittsburgh, USA.

出版信息

Cancer Immunol Immunother. 2004 Mar;53(3):240-8. doi: 10.1007/s00262-003-0468-6. Epub 2003 Dec 18.

DOI:10.1007/s00262-003-0468-6
PMID:14685779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11034253/
Abstract

Dendritic cells (DCs) are nature's best antigen-presenting cells. They possess attributes that allow them to effectively fulfill the requirements for priming/activating T cells and mediating tumor-specific immune responses. In this review, emphasis is placed on those aspects of DC biology that best illustrate their usefulness in immunotherapy of cancer. Culture, maturation, and polarization conditions for human DC are discussed, as are strategies for antigen-loading of DCs and for their delivery to patients with cancer. A concise recommendation for monitoring of DC-based vaccination trails is provided.

摘要

树突状细胞(DCs)是自然界中最佳的抗原呈递细胞。它们具有一些特性,使其能够有效地满足启动/激活T细胞以及介导肿瘤特异性免疫反应的要求。在本综述中,重点关注DC生物学中最能说明其在癌症免疫治疗中有用性的那些方面。讨论了人DC的培养、成熟和极化条件,以及DC抗原加载及其递送至癌症患者的策略。还提供了基于DC的疫苗接种试验监测的简要建议。